#USA #San Francisco #Pulse Health #ODAIA #Pharma Marketing

Introduction

In a noteworthy development announced at the JP Morgan Healthcare Conference, ODAIA and Pulse Health have revealed a groundbreaking technology partnership aimed at transforming marketing strategies within the pharmaceutical sector. By merging ODAIA's Campaign Intelligence capabilities with Pulse Health's Pulse Engagement Cloud, the collaboration seeks to automate and personalize healthcare professional (HCP) marketing campaigns, focusing on efficiency and effectiveness.

Campaign Automation and Effectiveness

The partnership has already shown promising results, with one of their joint clients implementing over 600 campaigns through the collaborative platform. ODAIA's advanced analytics identified 86% of the targeted HCPs for the pharma client while pinpointing an additional 14% where further marketing efforts would not yield better results. This strategic filtering helps eliminate unnecessary expenditures while optimizing marketing budgets.

Upon executing these targeted campaigns via Pulse Health's sophisticated platform, data revealed that 10% of HCPs engaged eventually moved on to writing prescriptions. Even more telling, 25% of those who converted increased their respective prescription volumes.

Key Features of the Collaboration

Ryan Alovis, CEO of Pulse Health, highlighted the significance of these outcomes, attributing them to the ability to execute data-driven, frictionless marketing engagements with HCPs. By harnessing ODAIA's insights within Pulse Health's compliant engagement framework, pharmaceutical brand teams can effectively relay relevant messages to targeted HCPs at the optimal time without the hassle of traditional manual campaign management.

The escalating challenge posed by tighter marketing budgets, smaller sales teams, and limited access to HCPs also underscores the necessity for pharma companies to maximize each interaction. Many firms currently depend on outdated consultant-created physician personas and rules-based channel sequences that are burdened by backward-looking data, a practice that lacks personalization and predictive intelligence.

Harnessing Real World Evidence (RWE)

ODAIA’s platform stands out by employing real-world evidence (RWE), market research, and customer data to develop predictive insights for personalized marketing campaigns. This allows for tailored recommendations regarding campaign strategies—encompassing channel selection, messaging content, type, and timing—based on individual HCP behaviors and patient eligibility.

Furthermore, automation through Pulse Health’s API streamlines the execution process, minimizing manual oversight and scheduling, while also integrating continuous performance feedback. This includes data on sales interactions, media exposure, email performance, and various behavioral signals, which are sent back to ODAIA’s Campaign Intelligence to inform future tailored sequences, thereby empowering marketers to prioritize strategic creativity while AI manages optimization.

A Vision for Personalized Interactions

Philip Poulidis, CEO of ODAIA, encapsulated the overarching vision for the partnership: to enable every interaction with HCPs to be personalized and responsive to genuine behavioral signals. He emphasized that the collaboration exemplifies the potential of AI-driven marketing orchestration to deliver quantifiable results.

As the partnership garners traction across various outreach avenues, ODAIA plans to enhance its integration of marketing and sales engagements throughout different touchpoints, synchronizing efforts with partners like Pulse Health to enable smarter, automated, omnichannel marketing efforts.

The integration of ODAIA's Campaign Intelligence alongside Pulse Health's engagement platform is currently available, with more activation partnerships on the horizon. This progressive collaboration represents a significant step towards elevating how pharma companies interact with healthcare professionals through innovative technology.

For those interested in discovering more about this partnership and its implications in the pharma marketing landscape, details can be found at www.odaia.ai/campaign-intelligence.

About ODAIA and Pulse Health

ODAIA

Recognized as a leader in AI-driven predictive commercial intelligence for the pharmaceutical industry, ODAIA helps biopharmaceutical corporations—some of which are among the top 15 globally—identify previously uncapitalized prescription opportunities and prioritize HCP outreach methodologies.

Pulse Health

In parallel, Pulse Health offers cloud-based promotional engagement services tailored for life sciences, empowering pharmaceutical brands with enhanced capabilities to connect and engage with healthcare professionals effectively. Their flagship product, Pulse Engagement Cloud, facilitates advanced marketing automation, detailed analytics, and seamless integration with prevalent pharmaceutical technology platforms.

Together, ODAIA and Pulse Health are reshaping the pharmaceutical marketing landscape, paving the way for more effective communication strategies that harness the potential of AI insights for enhanced prescriptive outcomes.